510(k) Report

510(k) · Cleared

Cleared

Cedia Cyclosporine Plus Assay

K023208510(k) TraditionalCleared Oct 24, 200229-day reviewClass II21 CFR 862.1235

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Microgenics Corp. · MKW Cyclosporine

Cleared on Oct 24, 2002 as substantially equivalent to P920031 (Dade Behring, Inc., 1996) after a 29-day review. Its family tree reaches back 1 generation to 1996.

Decided
Oct 24, 2002
Review
29 days
Class
Class II
Product code
MKW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to P920031 (1996). No later device cites it as a predicate yet.

P920031 · Emit 2000 Cyclosporine Specific Assay · Dade Behring, Inc. · 199619961998200020022004
  1. Root · 1 generation backP920031 Emit 2000 Cyclosporine Specific AssayDade Behring, Inc. · 1996
  2. This deviceK023208 Cedia Cyclosporine Plus AssayMicrogenics Corp. · 2002
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1P920031Emit 2000 Cyclosporine Specific AssayDade Behring, Inc.1996—
0 (this device)K023208Cedia Cyclosporine Plus AssayMicrogenics Corp.2002—
FIG. 1 — Lineage of K023208, 1996–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MKW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*P920031Emit 2000 Cyclosporine Specific Assay
Summary page 1
…EDIA Cyclosporine Plus Assay is substantially equivalent to EMIT 2000 Cyclosporine Specific Assay (Dade Behring Inc., San Jose, CA), cleared under premarket notification P92003 1 CEDIA Cyclosporine Plus Assay is identical or similar to its predicate in terms of intended use, method principle, device compone…
Dade Behring, Inc.1996—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All MKW devices

MKW Cyclosporine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MKW

3in 2008

2008: 3
2007high 3 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MKW

177in 2008

2008: 177 days median
2007high 177 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MKW

1in 2013

2010: 12011: 12013: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MKW

8in 2025

2010: 22011: 1082012: 362013: 302014: 42015: 22016: 42018: 32019: 42020: 22021: 62022: 72023: 52024: 62025: 8
2007high 108 (2011) · low 0 (2007)2025

MAUDE reports naming product code MKW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
2008317700
20090—00
20100—12
20110—1108
20120—036
20130—130
20140—04
20150—02
20160—04
20170—00
20180—03
20190—04
20200—02
20210—06
20220—07
20230—05
20240—06
20250—08
20260—0—

What is it indicated for?

The CEDIA Cyclosporine Plus Assay is for the quantitative determination of

cyclosporine in human whole blood using automated clinical chemistry analyzers as an

aid in the management of therapy in kidney, liver, and heart transplants. The CEDIA

Cyclosporine Calibrators are used to calibrate the CEDIA Cyclosporine Plus Assay in

human whole blood.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K023208: Cedia Cyclosporine Plus Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K023208

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026